SA watchdog to probe global giants over insulin pens
The lack of a bulk buying agreement forced South Africa to directly procure a limited number of insulin analogue pens outside ...
Biocon Biologics, Civica partner to expand Insulin Aspart access in the US
Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...
Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...
The Financial Express7d
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...
The Pharma Letter7d
Biocon and Civica link up on Insulin Aspart access in USA
Biocon Biologics unit and USA-based Civica Rx, a not-for-profit generic drug and pharmaceutical company, have announced a ...
Medical Dialogues7d
Biocon Biologics, Civica join hands to expand Insulin Aspart access in US
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...
Pharmabiz7d
Biocon Biologics and Civica collaborate to expand insulin aspart access in the US
Biocon Biologics and Civica Inc. not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, has inked a strategic ...
Becker's Hospital Review1d
Inside Civica Rx's 2025 sourcing, expansion strategies
President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...
The Cardiology Advisor9d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.